Skip to main
EBS

Emergent BioSolutions (EBS) Earnings Dates & Reports

Emergent BioSolutions (EBS) Most Recent Earnings

Report Date
Period EndingQ4 2025
Est. EPS$0.32
Actual EPS-$0.43
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Emergent BioSolutions (EBS) Earnings per Share (EPS) History

Signup for full access
Browse free

Emergent BioSolutions (EBS) Latest Earnings

The value each EBS share was expected to gain vs. the value each share gained.

Emergent BioSolutions (EBS) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.43. This exceeded analysts' expectations of $0.32 by 234.38%, marking a Miss.

For comparison, Emergent BioSolutions reported EPS of $0.05 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.17.

Emergent BioSolutions (EBS) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026
$0.17
Q4 2025
$0.32-$0.43-234.38%
Q3 2025
-$0.03$1.06-3,633.33%
Q2 2025
-$0.40$0.16-140.00%
Q1 2025
$0.44$0.71+61.36%
View all

Emergent BioSolutions (EBS) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Emergent BioSolutions’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Emergent BioSolutions (EBS) Earnings FAQs

Emergent BioSolutions (EBS) last reported earnings on Feb 26, 2026 for Q4 2025, posting an EPS of -$0.43, which Miss the estimate of $0.32 by 234.38%.

For Q4 2025, Emergent BioSolutions (EBS) reported an EPS of -$0.43, missing analysts' estimate of $0.32 by 234.38%.

For Q4 2025, Emergent BioSolutions (EBS) Miss expectations with an actual EPS of -$0.43 vs. an estimated EPS of $0.32.

Following the last earnings report on Feb 26, 2026, Emergent BioSolutions (EBS)'s stock price moved — from — to —.

The next Emergent BioSolutions (EBS) earnings call is scheduled for May. 6, 2026, where executives will discuss financial results and outlook.

Emergent BioSolutions (EBS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.